Ryan Stock, Hanson Nyantakyi‐Frimpong, Philip Antwi‐Agyei, Enoch Yeleliere,
... Situated in the impoverished Upper West region, the Kaleo Lawra solar plant serves as a grim admonition. ... research question: How has the development of the Kaleo Lawra solar plant influenced gendered livelihoods and resource ...
Tópico(s): Water Governance and Infrastructure
2023 - Elsevier BV | Energy Research & Social Science
Anna R. Wolfson, Emily M. Huebner, Kimberly G. Blumenthal,
... Fees/Honorarium: Allergenis, Aquestive, DVB Technologies, Genentech, Intrommune, Kaleo, Nutricia, Sanofi/Genzyme•William Johnson, MD, has no ... Fees/Honorarium: Allergenis, Aquestive, DVB Technologies, Genentech, Intrommune, Kaleo, Nutricia, Sanofi/Genzyme•William Johnson, MD, has no ...
Tópico(s): Antibiotic Use and Resistance
2019 - Elsevier BV | Annals of Allergy Asthma & Immunology
Sam Mehr, Terri Brown‐Whitehorn,
... Fees/Honorarium: Allergenis, Aquestive, DVB Technologies, Genentech, Intrommune, Kaleo, Nutricia, Sanofi/Genzyme•William Johnson, MD, has no ... Fees/Honorarium: Allergenis, Aquestive, DVB Technologies, Genentech, Intrommune, Kaleo, Nutricia, Sanofi/Genzyme•William Johnson, MD, has no ...
Tópico(s): Eosinophilic Disorders and Syndromes
2019 - Elsevier BV | Annals of Allergy Asthma & Immunology
... Editor): Consultant, Other financial gains: DBV Technologies, GlaxoSmithKline, Kaleo; Clinical Research, Grants: AstraZeneca, Boehringer Ingelheim, NovartisAuthorsThe following ... Editor): Consultant, Other financial gains: DBV Technologies, GlaxoSmithKline, Kaleo; Clinical Research, Grants: AstraZeneca, Boehringer Ingelheim, Novartis The ...
Tópico(s): Respiratory and Cough-Related Research
2018 - Elsevier BV | Annals of Allergy Asthma & Immunology
Vanitha Sampath, Sayantani Sindher, Wenming Zhang, Kari C. Nadeau,
... Consultant, Fees: AstraZeneca, Boehringer Ingelheim, DBV Technologies, GlaxoSmithKline, Kaleo, Novartis, SanofiAuthorThe following individuals have no relevant financial ... Consultant, Fees: AstraZeneca, Boehringer Ingelheim, DBV Technologies, GlaxoSmithKline, Kaleo, Novartis, Sanofi The following individuals have no relevant ...
Tópico(s): Allergic Rhinitis and Sensitization
2018 - Elsevier BV | Annals of Allergy Asthma & Immunology
Theophilus Tweneboah Kodua, Jacob Ankamah, Mary Addae,
... 110 sampled shea butter processors randomly selected from Kaleo in the Upper West region of Ghana. Profitability ...
Tópico(s): Cocoa and Sweet Potato Agronomy
2018 - Cogent OA | Cogent Food & Agriculture
David E. Tapke, Rebecca Scherzer, Mitchell H. Grayson,
... Editor): Consultant, Other financial gains: DBV Technologies, GlaxoSmithKline, Kaleo; Clinical Research, Grants: AstraZeneca, Boehringer Ingelheim, NovartisAuthorsThe following ... Editor): Consultant, Other financial gains: DBV Technologies, GlaxoSmithKline, Kaleo; Clinical Research, Grants: AstraZeneca, Boehringer Ingelheim, Novartis The ...
Tópico(s): Contact Dermatitis and Allergies
2018 - Elsevier BV | Annals of Allergy Asthma & Immunology
William J. Lavery, Jonathan A. Bernstein,
... Editor): Consultant, Other financial gains: DBV Technologies, GlaxoSmithKline, Kaleo; Clinical Research, Grants: AstraZeneca, Boehringer Ingelheim, NovartisAuthors•Jonathan ... Editor): Consultant, Other financial gains: DBV Technologies, GlaxoSmithKline, Kaleo; Clinical Research, Grants: AstraZeneca, Boehringer Ingelheim, Novartis Authors• ...
Tópico(s): Food Allergy and Anaphylaxis Research
2018 - Elsevier BV | Annals of Allergy Asthma & Immunology
... Editor): Consultant, Other financial gains: DBV Technologies, GlaxoSmithKline, Kaleo; Clinical Research, Grants: AstraZeneca, Boehringer Ingelheim, Novartis AuthorThe ... Editor): Consultant, Other financial gains: DBV Technologies, GlaxoSmithKline, Kaleo; Clinical Research, Grants: AstraZeneca, Boehringer Ingelheim, Novartis The ...
Tópico(s): Contact Dermatitis and Allergies
2018 - Elsevier BV | Annals of Allergy Asthma & Immunology
Matthew T. Stier, R. Stokes Peebles,
... J. Oppenheimer – Consultant for DBV Technologies, GlaxoSmithKline, and Kaleo, he received other financial gains; Clinical research for ... J. Oppenheimer – Consultant for DBV Technologies, GlaxoSmithKline, and Kaleo, he received other financial gains; Clinical research for ...
Tópico(s): Immune Cell Function and Interaction
2017 - Elsevier BV | Annals of Allergy Asthma & Immunology
Susan Waserman, Ernie Avilla, Moshe Ben‐Shoshan, Lana Rosenfield, Andrea Burke Adcock, Matthew Greenhawt,
... from the Canadian Transportation Agency, Nutricia, Nestle, Aimmune, Kaleo Pharmaceutical, Monsanto, and Intrommune Pharmaceutical; is an Associate ... from the Canadian Transportation Agency, Nutricia, Nestle, Aimmune, Kaleo Pharmaceutical, Monsanto, and Intrommune Pharmaceutical; is an Associate ...
Tópico(s): Contact Dermatitis and Allergies
2017 - Elsevier BV | The Journal of Allergy and Clinical Immunology In Practice
Neema Izadi, Donald Y.M. Leung,
... Editor): Consultant, Other financial gains: DBV Technologies, GlaxoSmithKline, Kaleo; Clinical Research, Grants: AstraZeneca, Boehringer Ingelheim, NovartisAuthor•Neema ... Editor): Consultant, Other financial gains: DBV Technologies, GlaxoSmithKline, Kaleo; Clinical Research, Grants: AstraZeneca, Boehringer Ingelheim, Novartis •Neema ...
Tópico(s): Asthma and respiratory diseases
2017 - Elsevier BV | Annals of Allergy Asthma & Immunology
... J. Oppenheimer – Consultant for DBV Technologies, GlaxoSmithKline, and Kaleo, he received other financial gains; Clinical research for ... J. Oppenheimer – Consultant for DBV Technologies, GlaxoSmithKline, and Kaleo, he received other financial gains; Clinical research for ...
Tópico(s): Blood groups and transfusion
2017 - Elsevier BV | Annals of Allergy Asthma & Immunology
... held autoinjector for naloxone manufactured by the company Kaléo. The pocket-sized device plays simple verbal instructions ... and delivers the drug through a retractable needle. Kaléo's CEO Spencer Williamson says that getting the ...
Tópico(s): Opioid Use Disorder Treatment
2014 - Elsevier BV | The Lancet
Mallory J. Gallant, Anne K. Ellis,
... Editor): Consultant, Other financial gains: DBV Technologies, GlaxoSmithKline, Kaleo; Clinical Research, Grants: AstraZeneca, Boehringer Ingelheim, NovartisAuthorThe following ... Editor): Consultant, Other financial gains: DBV Technologies, GlaxoSmithKline, Kaleo; Clinical Research, Grants: AstraZeneca, Boehringer Ingelheim, Novartis The ...
Tópico(s): Food Allergy and Anaphylaxis Research
2018 - Elsevier BV | Annals of Allergy Asthma & Immunology
Kannyiri Naaderi Jonas, Dogkubong Dinye Romanus,
... have been implemented in rural settings including Nadowli-Kaleo District of the Upper West Region, Ghana to ...
Tópico(s): Land Rights and Reforms
2017 - Academic Journals | African Journal of Agricultural Research
Eric Faakuu, Chrissie Stansie Abaidoo, Atta Kusi Appiah, Joshua Tetteh,
... 75 years and are permanent Dagaaba residents in Kaleo and Loho communities in the Nadowli-Kaleo District of the Upper West Region of Ghana ...
Tópico(s): Facial Rejuvenation and Surgery Techniques
2020 - Elsevier BV | Scientific African
Stacey A. Lapp, Joseph Y. Abrams, Austin Lu, Laila Hussaini, Carol Kao, David A. Hunstad, Robert B. Rosenberg, Marc J. Zafferani, Kaleo Ede, Wassim Ballan, Federico R. Laham, Yajira Beltran, Hui‐Mien Hsiao, Whitney Sherry, Elan Jenkins, Kaitlin Jones, A Horner, Alyssa D. Brooks, Bobbi Bryant, Lu Meng, Teresa A. Hammett, Matthew E. Oster, Sapna Bamrah-Morris, Shana Godfred‐Cato, Ermias D. Belay, Ann Chahroudi, Evan J. Anderson, Preeti Jaggi, Christina A. Rostad,
The serologic and cytokine responses of children hospitalized with multisystem inflammatory syndrome (MIS-C) vs coronavirus disease 2019 (COVID-19) are poorly understood.
Tópico(s): SARS-CoV-2 and COVID-19 Research
2022 - Oxford University Press | Open Forum Infectious Diseases
Shana Godfred‐Cato, Joseph Y. Abrams, Neha Balachandran, Preeti Jaggi, Kaitlin Jones, Christina A. Rostad, Austin Lu, Lucie Fan, Aysha Jabbar, Evan J. Anderson, Carol Kao, David A. Hunstad, Robert B. Rosenberg, Marc J. Zafferani, Kaleo Ede, Wassim Ballan, Federico R. Laham, Yajira Beltran, Bobbi Bryant, Lu Meng, Teresa A. Hammett, Matthew E. Oster, Sapna Bamrah Morris, Ermias D. Belay,
Distinguishing multisystem inflammatory syndrome in children (MIS-C) from coronavirus disease 2019 (COVID-19), Kawasaki disease (KD), and toxic shock syndrome (TSS) can be challenging. Because clinical management of these conditions can vary, timely and accurate diagnosis is essential.
Tópico(s): Mechanical Circulatory Support Devices
2022 - Lippincott Williams & Wilkins | The Pediatric Infectious Disease Journal
Elissa M. Abrams, Marcus Shaker, Ian Sinha, Matthew Greenhawt,
... Technologies, Sanofi/Genzyme, GlaxoSmithKline, Genentech, Nutricia, Pfizer, Novartis, Kaléo Pharmaceutical, Nestlé, US WorldMeds, Aquestive, Allergy Therapeutics, Allergenis, ...
Tópico(s): Respiratory viral infections research
2021 - Elsevier BV | The Lancet Respiratory Medicine
Suzanne C. Li, Kathryn S. Torok, Sarah S Ishaq, Mary Buckley, Barbara Edelheit, Kaleo Ede, Christopher Liu, C. Egla Rabinovich,
Abstract Objective To evaluate the safety and efficacy of abatacept treatment for refractory juvenile localized scleroderma (jLS) in a retrospective study. Methods A multicentre cohort study was performed to evaluate jLS subjects treated with abatacept with follow-up for 12 months to maximum of 24 months. Assessments at 6-month intervals included skin activity measures and physician global assessment of activity (PGA-A). Descriptive statistical analysis was performed. Results Eighteen subjects were ...
Tópico(s): Dupuytren's Contracture and Treatments
2020 - Oxford University Press | Lara D. Veeken
Ivan Venkonwine Kaleo, Qiang Gao, Bo Liu, Cunxin Sun, Qunlan Zhou, Huimin Zhang, Fan Shan, Zhe Xiong, Bo Liu, Changyou Song,
In order to study the effects of Moringa oleifera leaf extract on Macrobrachium rosenbergii under high ammonia exposure, freshwater prawns were randomly divided into five groups: a control group was fed with basal diet, and four treatment groups fed with basal diet supplemented with 0.25%, 0.5% and 1.0% M. oleifera leaf extract and 0.025% Enrofloxacin for 60 days, respectively. Then, freshwater prawns were exposed to high ammonia stress for 72 h and Vibro anguillarum infection. The growth, antioxidant ...
Tópico(s): Aquatic life and conservation
2019 - Elsevier BV | Fish & Shellfish Immunology
Joshua Sumankuuro, Mohammed‐Najeeb Mahama, Judith Crockett, Shaoyu Wang, Jeanine Young,
... youth, opinion leaders and healthcare providers in Nadowli-Kaleo and Daffiama-Bussie-Issa districts in the Upper ...
Tópico(s): Poverty, Education, and Child Welfare
2019 - BioMed Central | BMC Pregnancy and Childbirth
Daniel J. Lovell, Anne Johnson, Bin Huang, Beth S. Gottlieb, Paula Morris, Yukiko Kimura, Karen Onel, Suzanne C. Li, Alexei A. Grom, Janalee Taylor, Hermine I. Brunner, Jennifer Huggins, James J. Nocton, Kathleen Haines, Barbara Edelheit, Michael Shishov, Lawrence Jung, Calvin B. Williams, Melissa Tesher, D. Costanzo, Lawrence Zemel, Jason Dare, Murray H. Passo, Kaleo Ede, Judyann C. Olson, Elaine Cassidy, Thomas A. Griffin, Linda Wagner‐Weiner, Jennifer E. Weiss, Larry B. Vogler, Kelly Rouster‐Stevens, Timothy Beukelman, Randy Q. Cron, Daniel Kietz, Kenneth N. Schikler, Kara Schmidt, Jay Mehta, Dawn M. Wahezi, Tracy V. Ting, James Verbsky, B. Anne Eberhard, Steven Spalding, Chen Chen, Edward H. Giannini,
To determine the frequency, time to flare, and predictors of disease flare upon withdrawal of anti-tumor necrosis factor (anti-TNF) therapy in children with polyarticular forms of juvenile idiopathic arthritis (JIA) who demonstrated ≥6 months of continuous clinically inactive disease.In 16 centers 137 patients with clinically inactive JIA who were receiving anti-TNF therapy (42% of whom were also receiving methotrexate [MTX]) were prospectively followed up. If the disease remained clinically inactive ...
Tópico(s): Acute Lymphoblastic Leukemia research
2018 - Wiley | Arthritis & Rheumatology
Joshua Sumankuuro, Judith Crockett, Shaoyu Wang,
... work plan for maternal and newborn care.Nadowli-Kaleo and Daffiama-Bussie-Issa districts in Upper West ...
Tópico(s): Healthcare Systems and Reforms
2018 - BMJ | BMJ Open
... dose of 0.4 or 2 mg (EVZIO®; Kaléo, Inc., VA, USA) [23,24] and an intranasal ...
Tópico(s): Poisoning and overdose treatments
2018 - Future Medicine | Pain Management
Claas Hinze, Dirk Foell, Anne Johnson, Steven J. Spalding, Beth S. Gottlieb, Paula Morris, Yukiko Kimura, Karen Onel, Suzanne C. Li, Alexei A. Grom, Janalee Taylor, Hermine I. Brunner, Jennifer Huggins, James J. Nocton, Kathleen Haines, Barbara Edelheit, Michael Shishov, Lawrence Jung, Calvin B. Williams, Melissa Tesher, D. Costanzo, Lawrence Zemel, Jason Dare, Murray H. Passo, Kaleo Ede, Judyann C. Olson, Elaine Cassidy, Thomas A. Griffin, Linda Wagner‐Weiner, Jennifer E. Weiss, Larry B. Vogler, Kelly Rouster‐Stevens, Timothy Beukelman, Randy Q. Cron, Daniel Kietz, Kenneth N. Schikler, Jay Mehta, Tracy V. Ting, James Verbsky, A. Eberhard, Bin Huang, Edward H. Giannini, Daniel J. Lovell,
Objective To determine the relationship between serum levels of S100A8/A9 and S100A12 and the maintenance of clinically inactive disease during anti–tumor necrosis factor (anti‐ TNF ) therapy and the occurrence of disease flare following withdrawal of anti‐ TNF therapy in patients with polyarticular forms of juvenile idiopathic arthritis (JIA). Methods In this prospective, multicenter study, 137 patients with polyarticular‐course JIA whose disease was clinically inactive while receiving anti‐ TNF therapy ...
Tópico(s): Inflammation biomarkers and pathways
2018 - Wiley | Arthritis & Rheumatology
Cole Spencer, Kelly Rouster‐Stevens, Harry L. Gewanter, Grant Syverson, Renee Modica, Kara Schmidt, Helena Emery, Carol A. Wallace, Sriharsha Grevich, Kavita Nanda, YD Zhao, Susan Shenoi, Stacey E. Tarvin, S Hong, Carol B. Lindsley, JE Weiss, Murray H. Passo, Kaleo Ede, Amanda Brown, Kaveh Ardalan, William Bernal, M. L. Stoll, Bianca Lang, Ruy Carrasco, C Agaiar, L. Feller, Hülya Bükülmez, Richard K. Vehe, Hanna Kim, Heinrike Schmeling, Dana Gerstbacher, Mark F. Hoeltzel, B. Anne Eberhard, Robert P. Sundel, S. Kim, Adam M. Huber, Anjali Patwardhan,
The prognosis of children with juvenile dermatomyositis (JDM) has improved remarkably since the 1960's with the use of corticosteroid and immunosuppressive therapy. Yet there remain a minority of children who have refractory disease. Since 2003 the sporadic use of biologics (genetically-engineered proteins that usually are derived from human genes) for inflammatory myositis has been reported. In 2011-2016 we investigated our collective experience of biologics in JDM through the Childhood Arthritis ...
Tópico(s): Neurogenetic and Muscular Disorders Research
2017 - BioMed Central | Pediatric Rheumatology
Kaleo Almeida, David M. Jenkins,
Scapolites are widespread rock-forming aluminosilicates, appearing in metasomatic and igneous environments, and metamorphic terrains. Marialite (Na4Al3Si9O24Cl) is the Cl-rich end-member of the group. Even though Cl-rich scapolite is presumably stable over a wide range of pressure and temperature, little is known about its stability field. Understanding Cl-rich scapolite paragenesis is important since it can help identify subsurface fluid flow, metamorphic, and isotopic equilibration. Due to its ...
Tópico(s): Crystal Structures and Properties
2017 - Mineralogical Society of America | American Mineralogist
Robert B. Raffa, Robert Taylor, Joseph V. Pergolizzi, Srinivas Nalamachu, Eric S. Edwards, Evan Edwards,
... Recently, a novel naloxone auto-injector device (EVZIO, kaleo, Inc., Richmond, VA) was approved by the Food ...
Tópico(s): Musculoskeletal pain and rehabilitation
2016 - Springer Science+Business Media | Drug Delivery and Translational Research